Cue Biopharma, Inc. SEC filings CUE
Cue Biopharma, Inc. has 552 filings in SEC EDGAR's recent list, going back to Jun 19, 2015. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 21, 2026 | Sep 20, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 3, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Jul 10, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 2, 2026 | May 29, 2026 |
| 8-K | Current report | May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
May 1, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Apr 22, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Other events
|
Apr 7, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 24, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 20, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 10, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Apr 15, 2025 | Apr 14, 2025 |
| 8-K |
Current report
Material agreement
|
Apr 14, 2025 | Apr 10, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 12, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Oct 8, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 4, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 27, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 3, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 16, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 25, 2024 | Jul 24, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 14, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2023 | Apr 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2023 | Apr 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 15, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 22, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 30, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 18, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 1, 2021 | Oct 1, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2021 | Jun 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Material agreement
|
Nov 19, 2020 | Nov 18, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2020 | Sep 17, 2020 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Aug 24, 2020 | Aug 21, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 15, 2020 | Jul 9, 2020 |
| 8-K |
Current report
Material agreement
|
Jun 26, 2020 | Jun 24, 2020 |
| 8-K |
Current report
Material agreement
|
Jun 22, 2020 | Jun 22, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2020 | Jun 4, 2020 |
| 8-K |
Current report
Results of operations
|
May 19, 2020 | May 19, 2020 |
| 8-K |
Current report
Material agreement
|
Mar 27, 2020 | Mar 27, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2020 | Mar 17, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2020 | Mar 2, 2020 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Feb 10, 2020 | Feb 9, 2020 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Nov 26, 2019 | Nov 22, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2019 | Oct 3, 2019 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Oct 7, 2019 | Oct 3, 2019 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 6, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Material agreement
|
Jun 5, 2019 | Jun 5, 2019 |
| 8-K/A |
Amended current report
Material agreement, Regulation FD disclosure, Other events
|
Dec 26, 2018 | Nov 6, 2018 |
| 8-K/A |
Amended current report
Material agreement
|
Nov 13, 2018 | Nov 6, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 8, 2018 | Nov 6, 2018 |
| 8-K |
Current report
Officer or director change
|
Aug 3, 2018 | Jul 31, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 12, 2018 | Jul 12, 2018 |
| 8-K |
Current report
Officer or director change
|
Jun 26, 2018 | Jun 26, 2018 |
| 8-K |
Current report
Auditor change
|
Jun 25, 2018 | Jun 21, 2018 |
| 8-K |
Current report
Material agreement
|
Jun 20, 2018 | Jun 18, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2018 | Jun 12, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2018 | May 25, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2018 | May 17, 2018 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2018 | Apr 30, 2018 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 26, 2018 | Jan 22, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Dec 27, 2017 | Dec 27, 2017 |
Showing 84 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CUE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Somerville, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1645460
- Former names
- Imagen Biopharma, Inc. (until Jun 19, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.